ETF Components for EFA - iShares MSCI EAFE ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
NVO F 3.00 2.14
NVS D 0.27 1.28
TM D 0.51 1.08

Recent News for iShares MSCI EAFE ETF & its Holdings

Date Stock Title
Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
Nov 19 TM Toyota to begin testing hydrogen-electric hybrid vans in 2025
Nov 19 TM Philippine vehicle sales growth continues in October
Nov 18 NVO RFK Jr.'s HHS nomination sparks concern over pharma stocks
Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
Nov 18 NVO Novo Nordisk reportedly launches Wegovy in China
Nov 18 NVO How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
Nov 18 NVS Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Nov 18 NVO Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
Nov 18 NVS Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
Nov 18 TM Lovable LBX? – life with the little Lexus
Nov 18 NVO Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
Nov 17 TM Borderlands Mexico: Toyota pumping $1.45B into Mexico to boost Tacoma production
Nov 16 TM Toyota Slams California's 'Impossible' EV Mandate, Calls For National Regulation To Protect Consumers And Keep Manufacturing Viable
Nov 16 NVO The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
Nov 16 TM How NASCAR’s $7.7 billion media rights deal aims to modernize sport
Nov 15 TM Robby Starbuck declared war on DEI. Trump’s win could add momentum.
Nov 15 NVS FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI EAFE® Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index has been developed by MSCI Inc. ("MSCI") as an equity benchmark for its international stock performance. The underlying index includes stocks from Europe, Australasia and the Far East and, as of June 30, 2012, consisted of the following 22 developed market country indexes or regions.
Exchange Traded Fund ETF MSCI EAFE
Back to the Main EFA Page...